B

Bright Minds Biosciences Inc
CNSX:DRUG

Watchlist Manager
Bright Minds Biosciences Inc
CNSX:DRUG
Watchlist
Price: 58.27 CAD -1.24%
Market Cap: 260.1m CAD
Have any thoughts about
Bright Minds Biosciences Inc?
Write Note

Bright Minds Biosciences Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bright Minds Biosciences Inc
Income from Continuing Operations Peer Comparison

Comparables:
TH
RPTX
AUPH
COV
EDT

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
B
Bright Minds Biosciences Inc
CNSX:DRUG
Income from Continuing Operations
-CA$7.4m
CAGR 3-Years
-149%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Income from Continuing Operations
-$3.2m
CAGR 3-Years
51%
CAGR 5-Years
15%
CAGR 10-Years
10%
Repare Therapeutics Inc
NASDAQ:RPTX
Income from Continuing Operations
-$93.8m
CAGR 3-Years
-21%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Income from Continuing Operations
-$22.6m
CAGR 3-Years
47%
CAGR 5-Years
18%
CAGR 10-Years
-4%
Covalon Technologies Ltd
XTSX:COV
Income from Continuing Operations
-CA$823.4k
CAGR 3-Years
52%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Income from Continuing Operations
-CA$25.1m
CAGR 3-Years
-44%
CAGR 5-Years
-53%
CAGR 10-Years
-9%

See Also

What is Bright Minds Biosciences Inc's Income from Continuing Operations?
Income from Continuing Operations
-7.4m CAD

Based on the financial report for Sep 30, 2023, Bright Minds Biosciences Inc's Income from Continuing Operations amounts to -7.4m CAD.

What is Bright Minds Biosciences Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
-149%

Over the last year, the Income from Continuing Operations growth was 51%. The average annual Income from Continuing Operations growth rates for Bright Minds Biosciences Inc have been -149% over the past three years .

Back to Top